Outsourcing in Drug Development Market Report

Global Outsourcing in Drug Development Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：152
  • REPORT CODE：GMM876996
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Outsourcing in Drug Development market report explains the definition, types, applications, major countries, and major players of the Outsourcing in Drug Development market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Charles River Laboratories

    • Quintiles Transnational

    • ICON

    • Covance

    • PPD

    • Parexel

    • PRA Health Sciences

    By Type:

    • Clinical Trials

    • New Drug Application

    By End-User:

    • Pharmaceutical Industries

    • Biotechnology Industries

    • Medical Device Industries

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Outsourcing in Drug Development Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Outsourcing in Drug Development Outlook to 2028- Original Forecasts

    • 2.2 Outsourcing in Drug Development Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Outsourcing in Drug Development Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Outsourcing in Drug Development Market- Recent Developments

    • 6.1 Outsourcing in Drug Development Market News and Developments

    • 6.2 Outsourcing in Drug Development Market Deals Landscape

    7 Outsourcing in Drug Development Raw Materials and Cost Structure Analysis

    • 7.1 Outsourcing in Drug Development Key Raw Materials

    • 7.2 Outsourcing in Drug Development Price Trend of Key Raw Materials

    • 7.3 Outsourcing in Drug Development Key Suppliers of Raw Materials

    • 7.4 Outsourcing in Drug Development Market Concentration Rate of Raw Materials

    • 7.5 Outsourcing in Drug Development Cost Structure Analysis

      • 7.5.1 Outsourcing in Drug Development Raw Materials Analysis

      • 7.5.2 Outsourcing in Drug Development Labor Cost Analysis

      • 7.5.3 Outsourcing in Drug Development Manufacturing Expenses Analysis

    8 Global Outsourcing in Drug Development Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Outsourcing in Drug Development Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Outsourcing in Drug Development Export by Region (Top 10 Countries) (2017-2028)

    9 Global Outsourcing in Drug Development Market Outlook by Types and Applications to 2022

    • 9.1 Global Outsourcing in Drug Development Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Clinical Trials Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global New Drug Application Consumption and Growth Rate (2017-2022)

    • 9.2 Global Outsourcing in Drug Development Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical Industries Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Biotechnology Industries Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Medical Device Industries Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Outsourcing in Drug Development Market Analysis and Outlook till 2022

    • 10.1 Global Outsourcing in Drug Development Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Outsourcing in Drug Development Consumption (2017-2022)

      • 10.2.2 Canada Outsourcing in Drug Development Consumption (2017-2022)

      • 10.2.3 Mexico Outsourcing in Drug Development Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.2 UK Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.3 Spain Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.4 Belgium Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.5 France Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.6 Italy Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.7 Denmark Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.8 Finland Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.9 Norway Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.10 Sweden Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.11 Poland Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.12 Russia Outsourcing in Drug Development Consumption (2017-2022)

      • 10.3.13 Turkey Outsourcing in Drug Development Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.2 Japan Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.3 India Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.4 South Korea Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.5 Pakistan Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.6 Bangladesh Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.7 Indonesia Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.8 Thailand Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.9 Singapore Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.10 Malaysia Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.11 Philippines Outsourcing in Drug Development Consumption (2017-2022)

      • 10.4.12 Vietnam Outsourcing in Drug Development Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.2 Colombia Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.3 Chile Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.4 Argentina Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.5 Venezuela Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.6 Peru Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.7 Puerto Rico Outsourcing in Drug Development Consumption (2017-2022)

      • 10.5.8 Ecuador Outsourcing in Drug Development Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Outsourcing in Drug Development Consumption (2017-2022)

      • 10.6.2 Kuwait Outsourcing in Drug Development Consumption (2017-2022)

      • 10.6.3 Oman Outsourcing in Drug Development Consumption (2017-2022)

      • 10.6.4 Qatar Outsourcing in Drug Development Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Outsourcing in Drug Development Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Outsourcing in Drug Development Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Outsourcing in Drug Development Consumption (2017-2022)

      • 10.7.2 South Africa Outsourcing in Drug Development Consumption (2017-2022)

      • 10.7.3 Egypt Outsourcing in Drug Development Consumption (2017-2022)

      • 10.7.4 Algeria Outsourcing in Drug Development Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Outsourcing in Drug Development Consumption (2017-2022)

      • 10.8.2 New Zealand Outsourcing in Drug Development Consumption (2017-2022)

    11 Global Outsourcing in Drug Development Competitive Analysis

    • 11.1 Charles River Laboratories

      • 11.1.1 Charles River Laboratories Company Details

      • 11.1.2 Charles River Laboratories Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Charles River Laboratories Outsourcing in Drug Development Main Business and Markets Served

      • 11.1.4 Charles River Laboratories Outsourcing in Drug Development Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Quintiles Transnational

      • 11.2.1 Quintiles Transnational Company Details

      • 11.2.2 Quintiles Transnational Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Quintiles Transnational Outsourcing in Drug Development Main Business and Markets Served

      • 11.2.4 Quintiles Transnational Outsourcing in Drug Development Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 ICON

      • 11.3.1 ICON Company Details

      • 11.3.2 ICON Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 ICON Outsourcing in Drug Development Main Business and Markets Served

      • 11.3.4 ICON Outsourcing in Drug Development Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Covance

      • 11.4.1 Covance Company Details

      • 11.4.2 Covance Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Covance Outsourcing in Drug Development Main Business and Markets Served

      • 11.4.4 Covance Outsourcing in Drug Development Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 PPD

      • 11.5.1 PPD Company Details

      • 11.5.2 PPD Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 PPD Outsourcing in Drug Development Main Business and Markets Served

      • 11.5.4 PPD Outsourcing in Drug Development Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Parexel

      • 11.6.1 Parexel Company Details

      • 11.6.2 Parexel Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Parexel Outsourcing in Drug Development Main Business and Markets Served

      • 11.6.4 Parexel Outsourcing in Drug Development Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 PRA Health Sciences

      • 11.7.1 PRA Health Sciences Company Details

      • 11.7.2 PRA Health Sciences Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 PRA Health Sciences Outsourcing in Drug Development Main Business and Markets Served

      • 11.7.4 PRA Health Sciences Outsourcing in Drug Development Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Outsourcing in Drug Development Market Outlook by Types and Applications to 2028

    • 12.1 Global Outsourcing in Drug Development Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global New Drug Application Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Outsourcing in Drug Development Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmaceutical Industries Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Biotechnology Industries Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Medical Device Industries Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Outsourcing in Drug Development Market Analysis and Outlook to 2028

    • 13.1 Global Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.2.2 Canada Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.2 UK Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.3 Spain Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.5 France Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.6 Italy Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.8 Finland Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.9 Norway Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.11 Poland Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.12 Russia Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.2 Japan Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.3 India Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.3 Chile Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.6 Peru Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.6.3 Oman Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Outsourcing in Drug Development Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Outsourcing in Drug Development Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Outsourcing in Drug Development Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Outsourcing in Drug Development

    • Figure of Outsourcing in Drug Development Picture

    • Table Global Outsourcing in Drug Development Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Outsourcing in Drug Development Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Clinical Trials Consumption and Growth Rate (2017-2022)

    • Figure Global New Drug Application Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Industries Consumption and Growth Rate (2017-2022)

    • Figure Global Biotechnology Industries Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Device Industries Consumption and Growth Rate (2017-2022)

    • Figure Global Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Table North America Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure United States Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Canada Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Mexico Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table Europe Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure Germany Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure UK Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Spain Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Belgium Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure France Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Italy Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Denmark Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Finland Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Norway Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Sweden Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Poland Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Russia Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Turkey Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table APAC Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure China Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Japan Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure India Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure South Korea Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Thailand Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Singapore Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Philippines Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table South America Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure Brazil Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Colombia Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Chile Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Argentina Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Peru Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table GCC Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure Bahrain Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Oman Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Qatar Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table Africa Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure Nigeria Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure South Africa Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Egypt Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure Algeria Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table Oceania Outsourcing in Drug Development Consumption by Country (2017-2022)

    • Figure Australia Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Outsourcing in Drug Development Consumption and Growth Rate (2017-2022)

    • Table Charles River Laboratories Company Details

    • Table Charles River Laboratories Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table Charles River Laboratories Outsourcing in Drug Development Main Business and Markets Served

    • Table Charles River Laboratories Outsourcing in Drug Development Product Portfolio

    • Table Quintiles Transnational Company Details

    • Table Quintiles Transnational Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quintiles Transnational Outsourcing in Drug Development Main Business and Markets Served

    • Table Quintiles Transnational Outsourcing in Drug Development Product Portfolio

    • Table ICON Company Details

    • Table ICON Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICON Outsourcing in Drug Development Main Business and Markets Served

    • Table ICON Outsourcing in Drug Development Product Portfolio

    • Table Covance Company Details

    • Table Covance Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covance Outsourcing in Drug Development Main Business and Markets Served

    • Table Covance Outsourcing in Drug Development Product Portfolio

    • Table PPD Company Details

    • Table PPD Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table PPD Outsourcing in Drug Development Main Business and Markets Served

    • Table PPD Outsourcing in Drug Development Product Portfolio

    • Table Parexel Company Details

    • Table Parexel Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table Parexel Outsourcing in Drug Development Main Business and Markets Served

    • Table Parexel Outsourcing in Drug Development Product Portfolio

    • Table PRA Health Sciences Company Details

    • Table PRA Health Sciences Outsourcing in Drug Development Sales, Price, Value and Gross Profit (2017-2022)

    • Table PRA Health Sciences Outsourcing in Drug Development Main Business and Markets Served

    • Table PRA Health Sciences Outsourcing in Drug Development Product Portfolio

    • Figure Global Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global New Drug Application Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Industries Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biotechnology Industries Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Device Industries Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Table North America Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure United States Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure Germany Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure China Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure Brazil Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Outsourcing in Drug Development Consumption Forecast by Country (2022-2028)

    • Figure Australia Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Outsourcing in Drug Development Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US